Skip to main content

Table 4 Frequencies of the various complications according to type of treatment* among men aged between 50 and 69 with newly managed prostate cancer (PCa) in 2009 and still alive after two years, and comparison with two control groups without PCa, with or without surgical treatment for benign prostatic hyperplasia (BPH)

From: Prostate cancer outcomes in France: treatments, adverse effects and two-year mortality

 

Prostatectomy

External beam radiotherapy

Hormone therapy

Treated

Untreated

Control groups without PCA

PCa

PCa***

 

Alone

With another treatment**

Alone

Alone

All

 

Without BPH surgery

With BPH surgery

N

9,035

2,159

941

882

15,623

3,107

43,099

1,026

Mean age (years)

61.8

61.8

63.6

62.4

62.1

62.5

57.8

60.5

Complications

%

%

%

 

%

%

%

%

Erectile dysfunction

        

Two years

61.4

47.9°

7.2°

6.8°

45.8

9.6°

0.3°

1.5°

  Drug treatment

61.3

47.9

7.2

6.8

45.7

9.5

0.3

1.5

  Penile prosthesis

0.2

0.2

0.04

0.0

0.2

0.1

0.00

0.00

First year

53.2

38.1°

2.6°

4.7°

38.7

8.1°

0.2°

1.0°

  Drug treatment

53.1

38.1

2.6

4.7

38.6

8.0

0.2

1.0

  Penile prosthesis

0.1

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Second year

41.5

31.8°

6.3°

4.4°

30.8

6.4°

0.2°

1.1°

  Drug treatment

41.3

31.8

6.3

4.4

30.7

6.3

0.2

1.1

  Penile prosthesis

0.2

0.2

0.0

0.0

0.1

0.0

0.0

0.0

Urinary disorders

        

Two years

23.7

27.9°

14.4°

8.7°

21.6

12.3°

0.4°

5.6°

  Drug treatment

18.0

21.6

12.3

7.4

17.0

9.4

0.3

4.8

  External devices

7.7

9.3

2.4

1.8

6.3

3.8

0.1

0.8

  Surgical procedure

2.1

1.2

0.00

0.1

1.4

0.6

0.00

0.00

First year

20.1

22.8

10.9°

4.7°

17.5

10.4°

0.2°

3.7°

  Drug treatment

14.7

16.0

8.9

4.0

13.1

7.5

0.2

3.2

  External devices

7.2

8.9

2.2

1.1

5.8

3.3

0.1

0.5

  Surgical procedure

0.5

0.2

0.0

0.1

0.3

0.5

0.0

0.0

Second year

9.0

11.5°

7.6

6.0°

9.0

5.5°

0.2°

3.5°

  Drug treatment

7.2

10.3

5.7

4.8

7.6

4.2

0.2

3.0

  External devices

1.4

1.5

1.9

1.2

1.3

1.6

0.1

0.4

  Surgical procedure

1.7

1.0

0.0

0.1

1.1

0.2

0.0

0.0

Clot removal

        

  Surgical procedure

1.2

1.2

1.0

1.3

1.2

1.2

0.00°

0.3°

Urethral stricture

        

  Surgical procedure

1.6

1.9

1.5

1.1

1.4

2.2

0.0°

1.3

Bladder neck stenosis

        

  Surgical procedure

2.0

2.2

0.3°

1.0°

1.9

1.7

0.00°

0.9°

Radiation-induced inflammation

        

  Hospitalisation

0.0

1.1°

3.2°

0.1

0.7

0.3°

0.00°

0.00°

Acute urinary retention

        

  Surgical procedure

1.4

1.3

12.2

9.9°

3.5

19.3°

0.00°

3.6

Urethral-rectal fistula

        

  Hospitalisation

0.5

0.4

0.00

0.1°

0.3

0.0°

0.00°

0.00°

None

28.1

35.8°

69.3°

76.9°

40.1

63.5°

99.3°

89.0°

Drug treatment

        

  Antidepressants

11.3

11.4

12.2

15.9

12.0

12.2

7.1°

11.7

  Anxiolytics

15.3

18.1

21.1°

19.8

17.1

15.0°

10.4°

16.5

  1. *Hospitalisation: primary diagnosis, surgical treatment: presence of a specific surgical procedure code, external devices and medication: reimbursement codes.
  2. **Patients without treatment during the two years but with a primary diagnosis of PCa during hospitalisation or long-term chronic disease status for PCa.
  3. ***External beam radiotherapy and/or hormone therapy.
  4. Frequencies are age-standardised for men aged between 50 and 69 covered by the general scheme.
  5. °p < 0.05 for comparisons of frequencies between prostatectomy alone and prostatectomy combined with another treatment, external beam radiotherapy, for comparisons between untreated PCa and treated PCa, for comparisons between treated PCa and each control group.